MatchaBar is trying to turn the energy drink market on its head, and has even drawn interest -- and an investment -- from rap superstar Drake. Co-founder Graham Fortgang told Cheddar he and his brother/partner Max bet on live events and consumer packaged goods to give coffee the boot. “Whether we are doing a three-day activation out at Coachella, an event like TED Talks, [or] here on Cheddar TV,” he said, “a lot of what we do is get the brand into the spaces and into the communities that are influencing culture.” Not only has the family-owned business secured funding from Grammy-winner Drake, it also rolled out a national partnership with Whole Foods last September and teamed up with restaurant chain Dig Inn. This year, the team will be at festivals such as SXSW and New York’s Governors Ball. For full interview [click here](https://cheddar.com/videos/the-brothers-making-drakes-favorite-matcha).

Share:
More In Business
Poll: More Americans think companies benefit from legal immigration
A new poll finds U.S. adults are more likely than they were a year ago to think immigrants in the country legally benefit the economy. That comes as President Donald Trump's administration imposes new restrictions targeting legal pathways into the country. The Associated Press-NORC Center for Public Affairs Research survey finds Americans are more likely than they were in March 2024 to say it’s a “major benefit” that people who come to the U.S. legally contribute to the economy and help American companies get the expertise of skilled workers. At the same time, perceptions of illegal immigration haven’t shifted meaningfully. Americans still see fewer benefits from people who come to the U.S. illegally.
Tylenol maker rebounds a day after unfounded claims about its safety
Shares of Tylenol maker Kenvue are bouncing back sharply before the opening bell a day after President Donald Trump promoted unproven and in some cases discredited ties between Tylenol, vaccines and autism. Trump told pregnant women not to use the painkiller around a dozen times during the White House news conference Monday. The drugmaker tumbled 7.5%. Shares have regained most of those losses early Tuesday in premarket trading.
Load More